News

COVID-19 RESEARCH SUPPORT

To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac (www.adaptvac.com) and Bavarian Nordic (OMX: BAVA, OTC: BVNRY).

Read more:

www.healthsciences.ku.dk/newsfaculty-news/2020/03/ucph-researchers-receive-eu-grant-for-vaccine-against-coronavirus

www.news.ku.dk/all_news/2020/03/partnership-receives-grants-of-dkk-25m-from-the-carlsberg-foundation-to-fight-corona

This website uses cookies.

Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.